SEC Form D · filed November 29, 2022
Bonum Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (25)
Diane Hollenbaugh · Seattle, WAExecKarl Handelsman · Seattle, WADirectorNicholas Walrod · Seattle, WADirectorNeela Patel · Seattle, WAExecMonique Schiersing · Seattle, WADirectorJohn Mulligan · Seattle, WAExec · Director · PromoterJohn Mckearn · Seattle, WADirectorHeston Berkman · Orlando, FLExecMasahiro Koshiba · Minato-ku, Tokyo, M0Exec · Director · PromoterMadison Avenue Financial Solutions, LLC · Chicago, ILDirectorWashington Harbour Partners, LP · ARLINGTON, VADirectorSteven G. Lentz · Minneapolis, MNDirectorBlueArc Global Alternatives Management, LLC · Atlanta, GAExecJonathan Wells · Mt Pleasant, SCDirectorSamuel Bjork · Seattle, WADirectorMitchell Mutz · Cambridge, MADirectorFriends & Family Capital Management, LLC · MENLO PARK, CADirectorPaul Carram · Hoboken, NJExecCarlos Batista · Hoboken, NJExecDaniel Mingle · Sandy, UTDirectorDaniel Freeman · Ithaca, NYDirectorScott Lewis · Golden, CODirectorKimberly J. Melen · Grand Cayman, Cayman IslandsExec · Director · PromoterSamuel Bjork · Seattle, WADirectorMitchell Mutz · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗